申请人:Prosidion Limited
公开号:US08063247B2
公开(公告)日:2011-11-22
Compounds of formula (I) or pharmaceutically acceptable salts thereof, are opioid receptor modulators, e.g. mu-opioid receptor antagonists, neutral antagonists or inverse agonists, and are useful inter alia for the treatment of obesity.
式(I)的化合物或其药学上可接受的盐是阿片受体调节剂,例如μ-阿片受体拮抗剂、中性拮抗剂或反向激动剂,可用于治疗肥胖症等疾病。